Almaject Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALMAJECT, and what generic and branded alternatives to ALMAJECT drugs are available?
ALMAJECT has seven approved drugs.
Drugs and US Patents for Almaject
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almaject | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 065515-001 | Nov 8, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Almaject | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 204817-001 | May 17, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Almaject | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 062800-001 | Jul 24, 1987 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |